Literature DB >> 2524838

Molecular cloning of cDNA encoding Sm autoantigen: derivation of a cDNA for a B polypeptide of the U series of small nuclear ribonucleoprotein particles.

Y Ohosone1, T Mimori, A Griffith, M Akizuki, M Homma, J Craft, J A Hardin.   

Abstract

The Sm snRNPs play a central role in the processing of pre-mRNA. Anti-Sm antibodies, the diagnostic hallmark of systemic lupus erythematosus, target the B'/B and D polypeptides of these snRNPs. We have used patient autoantibodies to clone a cDNA from a human fibroblast cDNA library that encodes the full length of a polypeptide identical with, or closely related to, polypeptide B. This cDNA is comprised of 1139 bases and contains an open reading frame of 855 nucleotides that is capable of encoding 285 amino acids. The first 223 amino acids at the NH2 terminus exhibit nearly complete homology with polypeptide N, a newly recognized brain- and heart-specific component of Sm snRNPs. The derived amino acid sequence for B differs from that of the N polypeptide primarily by a 50-amino acid insert 12 residues upstream from the homologous COOH termini of these polypeptides. The structural differences in these cDNAs for B and N may regulate tissue-specific alternative splicing mechanisms for mRNA. In addition, these clones make it possible to map in fine detail the most characteristic autoimmune responses of systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2524838      PMCID: PMC287428          DOI: 10.1073/pnas.86.11.4249

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Characterization of U small nuclear RNA-associated proteins.

Authors:  P B Billings; S O Hoch
Journal:  J Biol Chem       Date:  1984-10-25       Impact factor: 5.157

Review 2.  Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

3.  Efficient isolation of genes by using antibody probes.

Authors:  R A Young; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

4.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

5.  Autoantibodies to the U2 small nuclear ribonucleoprotein in a patient with scleroderma-polymyositis overlap syndrome.

Authors:  T Mimori; M Hinterberger; I Pettersson; J A Steitz
Journal:  J Biol Chem       Date:  1984-01-10       Impact factor: 5.157

6.  The structure of mammalian small nuclear ribonucleoproteins. Identification of multiple protein components reactive with anti-(U1)ribonucleoprotein and anti-Sm autoantibodies.

Authors:  I Pettersson; M Hinterberger; T Mimori; E Gottlieb; J A Steitz
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

7.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

8.  Synthesis and assembly of human small nuclear ribonucleoproteins generated by cell-free translation.

Authors:  D E Fisher; G E Conner; W H Reeves; G Blobel; H G Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

9.  Antibodies from patients with connective tissue diseases bind specific subsets of cellular RNA-protein particles.

Authors:  J A Hardin; D R Rahn; C Shen; M R Lerner; S L Wolin; M D Rosa; J A Steitz
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

10.  Autoantibodies to ribonucleoprotein particles containing U2 small nuclear RNA.

Authors:  W Habets; M Hoet; P Bringmann; R Lührmann; W van Venrooij
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

View more
  15 in total

Review 1.  B-cell epitopes of Sm autoantigens.

Authors:  L A Rokeach; S O Hoch
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

Review 2.  Anti-Sm autoantibodies in systemic lupus erythematosus mice: a model system for disease-specific autoreactivity.

Authors:  R A Eisenberg
Journal:  Springer Semin Immunopathol       Date:  1992

Review 3.  snRNPs and scRNPs as autoantigens: clues to the etiology of the connective tissue diseases.

Authors:  J Craft; M Mamula; Y Ohosone; G Boire; H Gold; J Hardin
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

Review 4.  cDNA cloning of small nuclear and cytoplasmic RNA-associated proteins.

Authors:  A van Dam; I Winkel; R Smeenk; T Cuypers
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

5.  A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus.

Authors:  N Talal; R F Garry; P H Schur; S Alexander; M J Dauphinée; I H Livas; A Ballester; M Takei; H Dang
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

6.  A vector space model approach to identify genetically related diseases.

Authors:  Indra Neil Sarkar
Journal:  J Am Med Inform Assoc       Date:  2012-01-06       Impact factor: 4.497

Review 7.  RNA recognition by autoantigens and autoantibodies.

Authors:  J D Keene
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

8.  The herpes simplex virus type 1 regulatory protein ICP27 coimmunoprecipitates with anti-Sm antiserum, and the C terminus appears to be required for this interaction.

Authors:  R M Sandri-Goldin; M K Hibbard
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

9.  Analysis of variable region genes encoding anti-Sm and anti-cardiolipin antibodies from a systemic lupus erythematosus patient.

Authors:  C Demaison; C T Ravirajan; D A Isenberg; M Zouali
Journal:  Immunology       Date:  1995-11       Impact factor: 7.397

10.  Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen.

Authors:  Q Ge; D S Nilasena; C A O'Brien; M B Frank; I N Targoff
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.